The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors-Reference-Cited by-同舟云学术

The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors

Published:2015-07-15 Issue:7 Volume:10 Page:e0132821
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Czarniecka Agnieszka,Kowal Monika,Rusinek Dagmara,Krajewska Jolanta,Jarzab Michal,Stobiecka Ewa,Chmielik Ewa,Zembala-Nozynska Ewa,Poltorak Stanislaw,Sacher Aleksander,Maciejewski Adam,Zebracka-Gala Jadwiga,Lange Dariusz,Oczko-Wojciechowska Malgorzata,Handkiewicz-Junak Daria,Jarzab Barbara

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference58 articles.

1. Molecular pathogenesis and mechanisms of thyroid cancer;M Xing;Nat Rev Cancer,2013

2. BRAF mutation assessment in papillary thyroid cancer: are we ready to use it in clinical practice?;E Puxeddu;Endocrine,2014

3. The clinical and economic burden of a sustained increase in thyroid cancer incidence;B Aschebrook-Kilfoy;Cancer Epidemiol Biomarkers Prev,2013

4. Didkowska J., Wojciechowska U. ZW. Cancer in Poland in 2011. Polish Natl Cancer Regist Warsaw. 2013;http://onk:54:56

5. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer;GM Howell;Ann Surg Oncol,2013

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Significance of BRAF V600E Mutation and CPSF2 Protein Expression in Papillary Thyroid Cancer;Biomedicines;2022-12-26

2. Combined expression of the BRAFV600E mutation and PD-L1 in early papillary thyroid carcinoma and its relationship with clinicopathological features and recurrence—a retrospective cohort study;Gland Surgery;2022-12

3. Construction and validation of BRAF mutation diagnostic model based on ultrasound examination and clinical features of patients with thyroid nodules;Frontiers in Genetics;2022-09-08

4. Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma;BioMed Research International;2022-05-18

5. Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer;Frontiers in Endocrinology;2022-05-11